Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David M. Langenau, Ph.D.

Concepts (401)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with David Langenau's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that David Langenau has written about over time.
Microinjections, 4 publications between 2007 and 2011, average publication date July 2009. Animals, Genetically Modified, 34 publications between 2003 and 2022, average publication date February 2012. Cell Transformation, Neoplastic, 12 publications between 2003 and 2020, average publication date April 2012. Proto-Oncogene Proteins c-myc, 9 publications between 2004 and 2018, average publication date February 2013. Zebrafish, 72 publications between 2000 and 2023, average publication date June 2013. Disease Models, Animal, 20 publications between 2003 and 2021, average publication date June 2013. Neoplasm Transplantation, 16 publications between 2003 and 2019, average publication date March 2014. Zebrafish Proteins, 17 publications between 2002 and 2021, average publication date June 2014. Rhabdomyosarcoma, Embryonal, 9 publications between 2007 and 2022, average publication date July 2014. Cell Transplantation, 2 publications between 2014 and 2014, average publication date October 2014. Neoplastic Stem Cells, 8 publications between 2009 and 2018, average publication date November 2014. Receptor, Notch1, 2 publications between 2012 and 2017, average publication date November 2014. T-Lymphocytes, 13 publications between 2003 and 2024, average publication date January 2015. Muscle Neoplasms, 4 publications between 2011 and 2019, average publication date April 2015. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 15 publications between 2008 and 2022, average publication date June 2015. Rhabdomyosarcoma, 12 publications between 2009 and 2022, average publication date August 2016. Drug Discovery, 3 publications between 2013 and 2021, average publication date February 2018. Xenograft Model Antitumor Assays, 8 publications between 2017 and 2021, average publication date July 2019. Single-Cell Analysis, 6 publications between 2016 and 2022, average publication date March 2020. Lymphocyte Specific Protein Tyrosine Kinase p56(lck), 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Langenau's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (401)
Explore
_
Co-Authors (61)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.